RE: Drugs21 Aug 2023 17:13
I actually didn't pass any direct comment positive or negative on slimbiome medical. I did pass comment on our online site overall - which I still consider could be improved.
The loss of the CE mark presumably means it cannot be branded as a medical device within the EU - however we do not know how much the sales of slimbiome medical in EU make to the overall prebiotic sales (slimbiome/gofigure/wellbiome/leanbiome/slimbiomemedical/gummies etc) and thus we have to take at face value our company's decision not to renew the CE mark.
However that does not mean that slimbiome medical cannot continue to be sold - just not as a medical device within EU as far as i can decipher.
Since the end of 2022 through to April 2023 we have focused more on promoting SlimBiome® Medical as a unique
product which reduces hunger and cravings which can be used as part of any calorie restriction weight management plan. This has led to rapid growth with the ecommerce business reaching operational profitability in April and May 2023 with the highest monthly sales on record and a sales increase of 1,200% (Figure 1).
We are seeing good growth on the e-commerce platform, T-Mall, in China, particularly with sale of our
fruit gummies.
In 2023 we plan to grow our brands presence and securing listings on various channels including Amazon Europe and Amazon India whilst pushing hard for sales and customer loyalty. The addition of WellBiome® to the online store in May 2023 is part of a strategy to enhance the range of different product offerings and products on the website throughout
2023. Current product line extensions planned for SlimBiome® include a tomato and herb soup, a chicken soup, a Golden Syrup porridge, high protein chocolate bars and an indulgent range.
mol